» Articles » PMID: 7028073

Phagocytic and Bactericidal Activity of Human Neutrophils Against Two Isolates of Group B Streptococci Type Ic of Differing Pathogenicity

Overview
Journal Br J Exp Pathol
Specialty Pathology
Date 1981 Aug 1
PMID 7028073
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The phagocytic and bactericidal activities of normal adult human neutrophils against 2 strains of Group B streptococci Type Ic of differing pathogenicity were examined. Both isolates were phagocytosed by the neutrophils in the presence of normal and homologous immune serum. However, the highly pathogenicity streptococci were killed less readily in the presence of immune serum than were the streptococci of low pathogenicity in the presence of immune or normal serum. This difference in killing ability was not due to a defect in phagocytosis by the neutrophils, but to a defect in bactericidal activity. The highly pathogenic streptococci were not killed in the presence of normal serum, but were readily phagocytosed by the neutrophils, in which they accumulated and eventually caused their destruction. The streptococci of low pathogenicity, however, were killed equally as well in the absence of specific antibody as in its presence. It is suggested that an in vitro assessment of neutrophil function against streptococci of differing pathogenicity for mice may provide a useful method by which the pathogenicity of streptococci for man can be compared.

Citing Articles

Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).

von Hunolstein C, DAscenzi S, Wagner B, Jelinkova J, Alfarone G, Recchia S Infect Immun. 1993; 61(4):1272-80.

PMID: 8454331 PMC: 281358. DOI: 10.1128/iai.61.4.1272-1280.1993.


An alternative role for specific antibody in neutrophil bactericidal activity against highly pathogenic group B streptococci.

Cleat P, Coid C Br J Exp Pathol. 1982; 63(4):452-7.

PMID: 6817779 PMC: 2040641.


The mode of action of antibody in neutrophil bactericidal activity against highly pathogenic group-B streptococci.

Cleat P, Coid C Med Microbiol Immunol. 1984; 173(2):65-74.

PMID: 6387419 DOI: 10.1007/BF02124820.


Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.

Yeung M, Mattingly S Infect Immun. 1983; 42(1):141-51.

PMID: 6352490 PMC: 264535. DOI: 10.1128/iai.42.1.141-151.1983.


Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Payne N, Kim Y, Ferrieri P Infect Immun. 1987; 55(5):1243-51.

PMID: 3552996 PMC: 260497. DOI: 10.1128/iai.55.5.1243-1251.1987.


References
1.
ROGERS D, TOMPSETT R . The survival of staphylococci within human leukocytes. J Exp Med. 1952; 95(2):209-30. PMC: 2212057. DOI: 10.1084/jem.95.2.209. View

2.
Wilkinson B, Peterson P, Quie P . Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect Immun. 1979; 23(2):502-8. PMC: 414193. DOI: 10.1128/iai.23.2.502-508.1979. View

3.
Howard C, GLYNN A . The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement. Immunology. 1971; 20(5):767-77. PMC: 1455862. View

4.
Koch C . Acquired defect in the bactericidal function of neutrophil granulocytes during bacterial infections. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974; 82(3):439-47. DOI: 10.1111/j.1699-0463.1974.tb02348.x. View

5.
Jones J, Schwab J . Effects of streptococcal cell wall fragments on phagocytosis and tissue culture cells. Infect Immun. 1970; 1(3):232-42. PMC: 415886. DOI: 10.1128/iai.1.3.232-242.1970. View